Categories
Market News Top 10 News

Aarti Drugs Reports 12% YoY Decline in Net Profit in Q4 – Top Indian Market News

Aarti Drugs Q4 Results: Net profit declines 12% YoY to Rs 51.6 crore

Aarti Drugs reported a 12% year-on-year (YoY) decline in consolidated net profit to Rs 51.6 crore for the quarter ended March (Q4). Net profit has declined by 24% when compared to the previous quarter (Q3 FY21). The drugmaker’s net sales rose 11.6% YoY to Rs 501.75 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit has increased by 98.3% YoY to Rs 280.41 crore. Net sales have grown by 19.3% YoY to Rs 2,154.78 crore in FY21.

Read more here.

Kesoram Industries Q4 Results: Net profit at Rs 96.4 crore

Kesoram Industries reported a consolidated net profit of Rs 96.41 crore for the quarter ended March (Q4 FY21). It had posted a net loss of Rs 82.17 crore in the corresponding quarter a year ago (Q4 FY20). Net profit has jumped 80.5% when compared to the previous quarter (Q3 FY21). Revenue from operations rose to Rs 861.56 crore in Q4 FY21, compared with Rs 532.49 crore in the year-ago period. The company’s board has approved fundraising of up to Rs 600 crore, including a rights issue of Rs 200 crore. The funds will be utilised to repay debts.

Read more here.

Zensar Technologies to acquire US-based digital engineering firm M3bi

Zensar Technologies has signed definitive agreements to acquire M3bi, a US-based data engineering and digital engineering firm, for $30.6 million (~Rs 224 crore). The company will acquire the entire share capital of M3bi Private Ltd (M3bi India), while its wholly-owned subsidiary— Zensar Technologies Inc (USA) will acquire the entire share capital of M3bi LLC. This move will enhance Zensar Tech’s capabilities in the field of business intelligence and analytics, data warehousing & big data.

Read more here.

Pfizer likely to sell 50 million doses to India by Q3: Report

According to a report from the Times of India, drug manufacturer Pfizer is likely to sell 50 million doses of its Covid-19 vaccine to the Indian government by the third quarter of this year. The report states that the Centre is in ‘high-level’ discussions with Pfizer, which is proceeding in a successful direction. A recent study revealed that the Pfizer-BioNTech vaccine appeared to work against highly transmissible variants of Covid-19. 

Read more here.

Trident Q4 Results: Net profit rises 90.5% YoY to Rs 76.45 crore

Trident Limited reported a 90.5% YoY increase in consolidated net profit to Rs 76.45 crore for the quarter ended March (Q4). Net profit has declined by 31.8% when compared to the previous quarter (Q3 FY21). Its total revenue rose 35.69% YoY to Rs 1,344.95 crore during the same period. The company’s board has recommended a final dividend of Rs 0.36 per share.

Read more here.

Tata Steel approves conversion of 56.02 lakh partly-paid up shares

The Board of Directors of Tata Steel has approved the conversion of 56.02 lakh partly paid-up equity shares (Rs 2.504 paid-up) of the face value of Rs 10 each to fully paid-up equity shares of the face value of Rs 10 each, on which the first and final call money of Rs 461 per share has been received. The call money includes the face value of Rs 7.496 per share and securities premium of Rs 453.504 per share.

Read more here.

You can learn more about partly paid-up shares here.

Kirloskar Industries Q4 Results: Net profit rises 73% YoY to Rs 67.49

Kirloskar Industries reported a 73.72% YoY increase in consolidated net profit to Rs 67.49 crore for the quarter ended March (Q4). Its revenue from operations rose 63.5% YoY to Rs 750.82 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit has increased by 70.8% YoY to Rs 163.79 crore. The Board of Directors of Kirloskar Industries has recommended a dividend of Rs 10 per share. The company’s board has also approved an investment of up to Rs 15 crore in its wholly-owned subsidiary— Wellness Space Developers Ltd.

Read more here.

PNB closes QIP issue at 5% discount to floor price

Punjab National Bank (PNB) has closed its qualified institutional placement (QIP) offering with ~5% discount to the floor price of the issue. Equity capital was raised at Rs 33.75 per share, as against the floor price of Rs 35.53 per share fixed earlier by PNB. The bank has not revealed the actual amount it has raised through this QIP. PNB was looking to raise Rs 1,800 crore, including an option to retain oversubscription up to Rs 600 crore.

Read more here.

Geojit Financial Services Q4 Results: Net profit rises 94% YoY to Rs 36 crore

Geojit Financial Services Ltd reported a 94.08% YoY rise in consolidated net profit to Rs 36.39 crore for the quarter ended March (Q4). Net profit rose 18.8% when compared to the previous quarter (Q3 FY21). Its revenue from operations rose 47% YoY to Rs 121.38 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit has increased by 161.8% YoY to Rs 123.16 crore. The company’s board has recommended a final dividend of Rs 2 per share.

Read more here.

Quick Heal Tech Q4 Results: Net profit jumps 195% QoQ to Rs 39.7 crore

Quick Heal Technologies reported a 195% quarter-on-quarter (QoQ) jump in consolidated net profit to Rs 39.72 crore for the quarter ended March (Q4). Its revenue from operations rose 50% QoQ to Rs 105 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit has increased by 43.77% YoY to Rs 106.98 crore. The company’s board has recommended a final dividend of Rs 4 per share.

IRB InvIT’s Q4 distribution stands at Rs 2.5 per unit

IRB Infrastructure Investment Trust (InvIT) announced that it will be distributing Rs 2.5 per unit for Q4 FY21. This takes the overall distribution to unitholders to Rs 8.5 per unit for the financial year 2020-21. IRB InvIT owns, operates, and maintains a portfolio of toll road concessions in India. Its gross income for Q4 stood at Rs 334 crore, compared with Rs 316 crore in the corresponding period last year (Q4 FY20).

Devyani International files DRHP for Rs 1,400 crore IPO

Devyani International has filed a Draft Red Herring Prospectus (DRHP) with market regulator SEBI to raise Rs 1,400 crore through an initial public offering (IPO). The company is the largest franchisee of Pizza Hut, KFC, and Costa Coffee in India. The IPO comprises a fresh issue of Rs 400 crore and an offer for sale (OFS) of up to 12.53 crore equity shares by promoters.

Read more here.

Categories
Market News Top 10 News

Covid-19 Expert Panel Recommends SII’s Covishield for Emergency Use – Top Indian Market News

Covid-19 expert panel recommends SII’s Covishield for emergency use

The Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting emergency use authorisation (EUA) for ‘Covishield’, a Covid-19 vaccine developed by Oxford University and AstraZeneca. The Pune-based Serum Institute of India (SII) has tied up with AstraZeneca to manufacture Covishield in India. The Drugs Controller General of India (DCGI) will now take the final decision on emergency approval of the vaccine based on the expert panel’s recommendations.

After SII’s application, the SEC has started reviewing the EUA application by Bharat Biotech for its Covid-19 vaccine, Covaxin, and is yet to take a final decision on the matter.

Read more here.

Tata Sons overtakes GoI as largest promoter of listed companies

As per a report from Business Standard, Tata Sons has overtaken the Government of India (GoI) as the largest promoter of listed companies. This is the first time in nearly two decades that the government has not held the position. This has been due to the decline in the market capitalisation of state-run companies. The report states that Tata Sons’ stake in the conglomerate’s listed companies is now worth Rs 9.28 lakh crore, up 34.4% on a year-on-year (YoY) basis.

Read more here

Automobile companies register improved sales growth in December

Major automobile companies registered healthy sales growth during December 2020. Maruti Suzuki posted a 20.2% YoY increase in total sales at 1.60 lakh units in December, which was led by compact vehicles, LCVs, and vans. Mahindra & Mahindra announced that its overall passenger vehicle sales were up 3% YoY at 16,182 units, with a 3% growth in exports at 2,210 units. Escorts Ltd’s domestic tractor sales grew 90% YoY at 7,230 units, while exports were up 63.3% at 503 units.

Read more here.

WHO approves Pfizer-BioNTech vaccine for emergency use

The World Health Organization (WHO) announced that it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use. This means that poorer countries may soon get access to the shot, which is already available in Europe and North America. Every country that has a drug regulatory agency will have to issue its own approval for any COVID-19 vaccine. However, countries with weak systems usually rely on the WHO to vet the shots.

Read more here.

TCS completes acquisition of Postbank Systems from Deutsche Bank AG

Tata Consultancy Services (TCS), on Friday, said it has completed the acquisition of 100% shares of Postbank Systems AG (PBS) from Deutsche Bank AG. PBS has been the internal IT provider for Postbank AG, a subsidiary of Deutsche Bank. It caters to the German retail banking market. In November 2020, TCS had announced its plans to acquire Postbank Systems through its subsidiary, Tata Consultancy Services Netherlands B.V.

Read more here.

Praj Industries bags Rs 226 crore order from Indian Oil Corporation

Praj Industries Ltd, on Friday, said it has bagged a Rs 226.90 crore order from Indian Oil Corporation Ltd (IOCL). The company stated that the order is for the execution of a zero liquid discharge system – water treatment package and wastewater treatment package of Acrylic/Oxo-Alcohol Project, at IOCL Dumad in Gujarat. Praj Industries is a Pune-based industrial biotechnology company.

Read more here.

Coal India output rises 6% to 157 million tonnes in Q3

Coal India Ltd’s output grew 6.3% YoY at 156.8 million tonnes (MT) during the October-December quarter (Q3). The company had reported an output of 147.5 MT during the same period in the previous financial year (FY20). The state-owned mining company also posted over 9% YoY growth in offtake at 154.6 MT during Q3 FY21. [Coal offtake is the amount of coal supplied from the coal mine]

Read more here.

Gayatri Projects declared lowest bidder for road project worth Rs 1,323 crore

Gayatri Projects Ltd said it has been declared as the lowest bidder for a road project worth Rs 1,323.52 crore. The company has been declared as an L-1 bidder for the development of a six-lane access-controlled highway in the Uttar Pradesh portion of the Delhi-Saharanpur Highway. Gayatri Projects is a Hyderabad-based construction engineering company.

Read more here.

Dabur launches ‘Dabur Red Pulling Oil’, an Ayurvedic mouthwash

Dabur India Ltd has announced its entry into the mouthwash category with the launch of Dabur Red Pulling Oil, an Ayurvedic mouthwash. The launch of this Ayurvedic detox for teeth and gums marks another first for Dabur and the Ayurvedic products industry in India. Priced at Rs 275 for a 195ml pack, Dabur Red Pulling Oil is initially available across all leading e-commerce platforms and will soon be rolled out through regular retail channels.

Adani Green secures 600 MW wind-solar hybrid power project

Adani Green Energy announced that its subsidiary, Adani Renewable Energy Holding Eight Ltd, has received the contract to build a 600 megawatts (MW) wind-solar hybrid power project. This will take the company’s total project portfolio to 14,795 MW. The fixed tariff for this project is Rs 2.41 per unit for a period of 25 years. The project is scheduled to be commissioned in 18 months from the effective date of the power purchase agreement.

Read more here.


Categories
Market News Top 10 News

USA, Mexico Authorizes Emergency Use of Pfizer Vaccine – Top Market News

USA, Mexico authorizes emergency use of Pfizer vaccine

The US Food and Drug Administration (USFDA) and Mexico’s drug regulator- Cofepris have authorized the Covid-19 vaccine developed by Pfizer-BioNTech for emergency use in their respective countries. So far, the Pfizer-BioNTech vaccine has been approved for emergency use in a total of five countries- the United Kingdom, Bahrain, Canada, the United States, and Mexico.

India’s economic recovery faster than expected: PM Modi

Prime Minister Narendra Modi, on Saturday, stated that economic indicators have shown encouraging signs of recovery of the Indian economy. He stated that India has seen record Foreign Direct Investment (FDI) and Foreign Portfolio Investment (FPI) inflows during the pandemic. PM Modi was addressing FICCI’s 93rd Annual General Meeting and Annual Convention via video conferencing. On farm laws, PM Modi said that that the new reforms will give farmers new markets and access to technology. He further stated that the farm reforms will help bring investments in agriculture that will benefit farmers.

Read more here.

Yes Bank sells 2.56% stake in Coffee Day group-owned Sical Logistics

Yes Bank has sold 15 lakh shares, which is equivalent to a 2.56% stake, in Sical Logistics. The nominal value of each share was Rs 10. Sical was acquired by Coffee Day group in 2011. It is engaged in customs handling, trucking & steamer agency businesses, mining, port logistics, road & rail transport, etc.

Read more here.

Finance Ministry approves Rs 9,879 crore capital expenditure proposal of 27 states

The Finance Ministry has approved Rs 9,979.61 crore worth of capital expenditure proposals of 27 states. Out of the total amount, Rs 4,939.81 crore has been released as the first installment. This is part of the newly announced government scheme for ‘Special Assitance to States for Capital Expenditure’, under the Atmanirbhar Bharat package.

Read more here.

L&T to win orders worth Rs 5,500 crore, including NPCIL and Chennai Metro Rail jobs: Report

According to a report from ET Prime, Larsen & Toubro (L&T) has emerged as the lowest bidder for three orders worth around Rs 5,500 crore. This includes a contract from the Nuclear Power Corporation of India (NPCIL) for its Kudankulam project. The two other orders are from Chennai Metro Rail and energy major Oil & Natural Gas Corporation (ONGC). The report states that L&T is likely to officially receive the orders from these clients in the last quarter of 2020-21.

Read more here.

Tata Motors offers VRS scheme to control costs

Tata Motors Ltd has offered a voluntary retirement scheme (VRS) to its employees, in an effort to control costs and efficiently implement its turnaround plans. The VRS scheme is open till January 9, 2021, and will cover nearly half of Tata Motors’ 42,957 employees. This is the third time in four years that Tata Motors is floating a VRS. 

Read more here.

Banks select Vedanta’s offer of Rs 5,000- Rs 6,000 crore for Videocon: Report

According to a report from ET Prime, banks have selected Vedanta group’s Rs 5,000- Rs 6,000 crore offer for the debt-ridden Videocon Industries. The Vedanta group was engaged in negotiations with a group of lenders, led by State Bank of India, after submitting its first offer. The final offer by Vedanta would imply the recovery of 16-20% of the total dues of Videocon to its lenders. Videocon Industries owes banks Rs 30,000 crore, including interest accumulated over the years.

Read more here.

Violence brakes out at Wistron Corp’s iPhone manufacturing plant near Bengaluru

Workers at Wistron Corporation’s factory in Narasapura (near Bengaluru) went on a rampage on Saturday morning over the non-payment of wages and extended working hours. The protesters raised slogans against the management, pelted stones at the office, and set fire to a company name board. According to reports, 80 employees of Wistron have been arrested so far. Taiwan-based Wistron Corp is a contract manufacturer for Apple iPhones.

Read more here.

ICICI Prudential’s assets under management cross Rs 2 lakh crore

ICICI Prudential Life Insurance Company’s assets under management (AUM) have crossed Rs 2 lakh crore, as it entered its 20th year of operations. AUM is the total market value of the investments that an entity manages on behalf of clients. The company stated that this milestone demonstrates its steadfast focus on customer-centricity and the commitment of its employees and other stakeholders.  

Read more here.

Board of Zensar Tech approves change in MD and CEO

The Board of Zensar Technologies Ltd announced that Ajay Bhutoria will be succeeding Sandeep Kishore as Chief Executive Officer and Managing Director. Prior to this, Ajay Bhutoria was chief executive of L&T-NxT, before which he was country head of Cognizant Switzerland. Sandeep Kishore, who had been appointed for five years, shall leave on January 11, 2021 (after his term ends). 

Read more here.

Categories
Editorial

Can Snowman Logistics Benefit From Covid-19?

Coronavirus has impacted everyone’s life. It’s been 9 months already but India, along with most nations, is still struggling to contain the spread of the virus. As of 2nd December, India is very close to 1 crore positive cases. All the hopes lie on scientists worldwide to discover the vaccine. Many possible vaccines have been rolled out in the past two months which are close to getting approvals from the various authorities. To know more about these possible vaccines, click here.

Discovering and testing vaccines is one challenge, but distributing them is another. As the launch of a vaccine comes near, it’s quite natural that focus will shift to many logistics companies as well. One such logistics company is Snowman Logistics.

About Snowman

Snowman is India’s leading integrated temperature-controlled logistics company. Incorporated by Amalgam Foods Limited in 1993, it is India’s first cold supply chain company with a nationwide network. Gateway Distriparks Limited is their promoter and largest shareholder.

With over 25 years of experience in temperature-controlled warehousing and transportation, Snowman has been able to gather some big clients. These clients are from various businesses like pharmaceuticals, QSR (Quick Service Restaurants), meat, seafood, dairy, retail, etc. Few of the client companies to name are ITC, Lupin, Walmart, Pepsi, Pizza Hut, Mother Dairy, Mondelez, Bharat Biotech (potential vaccine manufacturer) and more. Snowman offers a variety of services from consultancy to transportation to distribution. 

The chart below will explain their end-to-end solutions in a detailed manner.

[Source: Snowman’s corporate presentation]

The products which Snowman deals with are temperature-controlled. Due to this, it becomes very important to take special care of them. To get real-time updates, Snowman has incorporated an ERP system. This ERP system is a technology with which they trace all their trucks and warehouses. This real-time monitoring helps them to optimize and secure their operations. Currently, they hold pallet capacity of 105,228 in 31 warehoused across 15 cities. These 15 cities include Kochi, Chennai, Banglore, Mumbai, Delhi, Ahmedabad, etc. You can find Snowman’s 2019-20 annual report here.

Pfizer & Snowman

US-based Pfizer Inc and Germany-based BioNTech developed a vaccine which proved to be 95% effective in preventing Covid-19. The UK government became the first country on 2nd December to approve the use of Pfizer-BioNTech’s covid-19 vaccine. Reports suggest that this vaccine will be available across the UK from next week. The US Food and Drug Administration (FDA) will meet on 10th December to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc.

Can it come to India? There are many roadblocks of this vaccine coming to India. The biggest is the temperature it has to be stored and transported. According to reports, Pfizer’s vaccine requires an ultra-cold chain of -70 degrees. India does not have many logistics companies which can provide logistics services at such low temperature. Snowman Logistics is one of the very few Indian companies which can offer services similar to what is required by Pfizer’s vaccine.

According to Snowman’s CEO Sunil Nair, their current facilities can provide logistics and storage up to -40 degrees. But if it requires more than that, any company in the world will find it hard to offer their services if the technology is not improved. He added “Going up to -40 degree Celcius if I take that as then we have one lakh pellets positions total capacity and as of now the spare capacity is around 15,000 pellets positions and depending on the requirement we can increase it by creating some more space. Each pellet can accommodate 6000-7000 doses of vaccine.” 

The sudden rise in Snowman’s share price 1-Day candle

The day Pfizer’s vaccine news came out, Snowman Logistics’ share went 8% up. The chart below depicts how the investors have got behind this stock. In March, the stock touched its 52-week low at Rs 24.60. Since then, it has really struggled to get back up. Till 3rd November, the stock was trading in the early 30s. In just one month, it went from Rs 34 to Rs 67.30. Almost a double! That’s why it is often said that the stock market is unpredictable. But believe us, if you know the fundamental reason behind the happenings, you will always be a better and a knowledgeable investor in the long-run.

Financial Performance of Snowman Logistics

The company may have an amazing business opportunity, but how strong are they fundamentally? Let’s check out.

March 2020March 2019March 2018
Net Sales240.20232.55194.28
EBITDA60.1946.7944.46
PBT-6.3110.86-3.56
Values in Rs Crore

Snowman Logistics registered a mere 3% YoY rise in total revenue in FY20. But at the same time, they failed to record a profit for the third time in the last four years. Between 2017 to 2020, they recorded a profit only once and it was in 2019. This is mostly because of the high depreciation. In FY20, the company calculated total depreciation to be more than Rs 50 crore. That means, more than one-fifth of their total revenue was lost in covering for depreciation.

On a positive side, Snowman Logistics reported a positive net cash flow for the first time in the last five years. The company reported a net cash inflow of Rs 1.13 crore. Apart from depreciation, a major chunk of Snowman’s money goes out to pay the debt. They have maintained a very low debt-toequity ratio which means most of the money has come through equity rather than debt. Snowman’s current debt-to-equity ratio is 0.15. This ratio was 0.32 in 2018. Overall, the company has not performed well financially over the past 5 years. Yet, the continuous decreasing debt pattern provides a brighter look to the company. Any company which has less debt, with a good market to compete in, is considered less risky by the investors. You can also look into its peer cold supply chain companies like Blue Star.

In another note, Adani Logistics offloaded approximately 9.59 lakh equity shares indicating 0.57% stake in the company at Rs 55.64 per share last day. This is not looking like a good sign.

Be it vaccines or FMCG products, cold-chain supply in India is set to witness a boom. Can Snowman Logistics take advantage of this? Or will the stock fall after the recent rally based on potential vaccine news be futile? Let us wait and watch.

Categories
Trending

Pfizer-BioNTech Vaccine Gets Approval in UK

UK has become the first country to license a vaccine against Covid-19. Pfizer’s vaccine had a 95% efficacy rate from their clinical trials and it has now been authorised for emergency use by the Medicines and Healthcare Products Regulatory Authority (MHRA). The MHRA in UK was given the power to approve the vaccine by the government under special regulations. The vaccine will be available in Britain as early as next week, according to a government statement. 

Britain’s vaccine committee will decide which priority groups will get the first shot such as health care staff and workers, and people who are in high-risk of contracting the virus. However, it is not much news to cheer for India as the vaccine would not be available in India because Pfizer’s vaccine require an ultra-cold chain of minus 70 degree, currently India has no such facilities available.

There could also be an outflow of money of Foreign Institutional Investors from India to European markets. So be cautious while entering into trades. To know more about the stocks that could gain from the approval of vaccine in India, click here.

Categories
Market News Top 10 News Top Global News

Giant U.K. Retailers go Bankrupt – Top 10 Global News

1. Stocks Bounce Back With U.S. Futures; Dollar Slips

Global stocks and U.S. futures are starting December on a bullish note with a rebound from Monday’s retreat. Cyclical shares led the Stoxx Europe 600 Index higher as banks, miners and energy firms climbed. U.K. stocks were up almost 2% after Goldman Sachs strategists called them a buy ahead of a Brexit trade deal. The risk-on mood carried across other markets. Bitcoin is approaching $20,000 and futures on the Russell 2000 Index of small-cap stocks outperformed the tech-heavy Nasdaq 100 Index. The dollar weakened against most of its major peers.

Futures on the S&P 500 Index increased 0.8% as of morning London time.

The Stoxx Europe 600 Index gained 0.9%.

The MSCI Asia Pacific Index rose 1%.

The MSCI Emerging Market Index rose 1.2%.

2. Pfizer, BioNTech Seek EU Clearance for Covid-19 Vaccine

Pfizer and BioNTech sought regulatory clearance for their Covid-19 vaccine in the European Union, putting the shot on track for potential approval there before the end of the year. The European Medicines Agency said it could issue an opinion within weeks, with a meeting on the assessment scheduled for Dec. 29 at the latest. Submitted on Monday, the formal application caps a rolling review process that started on Oct. 6 and allowed Europe’s drugs regulator to examine data on the vaccine as it emerged. Governments around the world are eager to start vaccinating their populations to curb the pandemic. Rival Moderna requested clearance in the U.S. and Europe on Monday. The U.K. invoked a special rule to allow its regulator to bypass its EU counterpart and maybe the first to sign off on the Pfizer-BioNTech product. The U.S. isn’t far behind, with a Food and Drug Administration panel set to meet on Dec. 10 to discuss the vaccine.

3. Exxon Faces Historic Writedown After Energy Markets Implode

Exxon Mobil is about to incur the biggest writedown in its modern history as the giant U.S. oil and gas producer reels from this year’s collapse in energy prices. Exxon — traditionally far more reluctant to cut the book value of its business than other oil majors — on Monday disclosed it will write down North and South American natural gas fields by $17 billion to $20 billion. That could make it the industry’s steepest impairment since BP’s 2010 Gulf of Mexico oil spill that killed 11 workers and fouled the sea for months. Meanwhile, capital spending will be drastically reduced through 2025. The announcement comes in the waning days of a gruelling year for Chief Executive Officer Darren Woods, who’s resorted to laying off thousands of employees, curtailing retirement benefits and cancelling ambitious growth projects. 

4. Two U.K. Retail Collapses Threaten 25,000 Jobs in 24 Hours

The U.K. retail industry suffered one of the harshest blows yet after two of the country’s best-known retailers collapsed, putting 25,000 jobs at risk in less than 24 hours. Debenhams said Tuesday morning it’s preparing to close its doors for good after failing to find a buyer. Late Monday, Philip Green’s Arcadia Group, which owns brands including Topshop and Dorothy Perkins, began insolvency proceedings. Both retailers have anchored malls and main streets across Britain for decades and operate about 600 stores combined. U.K. retailers have suffered a double whammy: the pandemic hit as many were struggling to adjust to online competition. The industry is set to lose 235,000 retail jobs this year, according to the Centre for Retail Research.

5. European Central Bank Warns Against Hopes for Blockbuster Stimulus

The European Central Bank should focus on keeping financial conditions at current levels through the crisis rather than announcing a blockbuster stimulus package that beats market expectations, according to Executive Board member Isabel Schnabel. Just over a week before the ECB Governing Council’s policy decision, Schnabel confirmed that more support is likely because the pandemic will be more protracted than expected. But she also noted that borrowing costs have dropped to record lows because of monetary and fiscal aid, and what is most important is sustaining that state of affairs until the crisis is past.

6. Pound Rises as Traders Bet on Brexit Breakthrough Within Days

The pound advanced to the highest level in three months as anticipation grew that the U.K. and European Union may strike a trade deal soon. Pound sterling rose as much as 0.6%, sending the currency above September-highs. Irish Prime Minister Micheal Martin told the Irish Times he’s hopeful for a Brexit deal by the end of the week, echoing similar comments by French European Affairs Minister Clement Beaune. With time running short to ratify any agreement before the transition period ends on Dec. 31, momentum is building for a pact. It was spurred by relief the U.K. and EU seemed willing to negotiate a deal and on optimism over the developments of several Covid-19 vaccinations.

7. Xiaomi Seeks Up to $4 Billion in Shares, Convertible Bonds

China’s No. 2 smartphone maker Xiaomi Corp. is seeking to raise as much as $4 billion from a combined share placement and sale of convertible bonds, adding to a war chest aimed at expanding its market share from competitor Huawei. Xiaomi is selling 100 crore shares in a top-up placement to raise as much as $3.2 billion. Xiaomi is also seeking $855 million through a seven-year, zero-coupon convertible bond. Xiaomi shares had been on a rally this year, rising 146% from a year ago. However, its stock slipped after it disclosed that its internet services revenue had grown at its slowest pace in three years in the September quarter. It grabbed market share from Huawei when American sanctions deepened particularly in overseas markets from Europe to India.

8. OPEC+ Talks Delayed as Split Deepens Between Key Gulf Allies

OPEC+ talks were delayed for two days to give ministers more time to reach a deal, after a long and tense meeting on oil production broke down without an agreement. The move was the most dramatic sign yet of the deep division inside the cartel after hours of talks on Monday yielded no result. Oil prices, which have rallied on vaccine hopes as well as expectations that OPEC will maintain its current output curbs, slipped on the news. OPEC ministers met on Monday and had been scheduled to talk to their non-OPEC partners on Tuesday. At one point, there had appeared to be a consensus building between ministers yesterday, but the meeting then became unusually fraught. The run-up to the meeting saw new cracks emerge in the relationship between the United Arab Emirates — a core part of the group — and other members. The UAE’s national long-term strategy to crank up production is clashing with the cartel’s current restrictions.

9. Oyo Has $1 Billion to Fund Operations Until IPO, CEO Tells Employees

Ritesh Agarwal, founder and CEO of Oyo Hotels, told employees the Indian startup is making progress in recovering from the coronavirus fallout and has about $1 billion (INR 7500 cr) to fund operations until an IPO. The 27-year-old entrepreneur made the comments in a fireside chat with Oyo board member Troy Alstead, after the once high-flying company endured months of layoffs and losses as Covid-19 hammered its business. Oyo is one of the largest startups in the portfolio of SoftBank Group, reaching a valuation of $10 billion (INR 75,000 cr) before the downturn. Agarwal said the company’s focus is on getting revenue per available room to 60% to 80% of pre-pandemic levels across all markets. India, China, Japan and Southeast Asia are making progress in reaching that range, he added.

10. Wendy’s to Open 250 Cloud Kitchens in India as Virus Hits

Wendy’s has struck a deal with India’s Rebel Foods to open about 250 cloud kitchens across the country, one of the most ambitious efforts yet to serve customers through delivery rather than the traditional fast-food stores as the industry adapts to the coronavirus pandemic. The U.S. company is experimenting with a new format as the Covid-19 outbreak makes many consumers unwilling or unable to visit traditional stores. Cloud kitchens, which derive their name from cloud computing, are remote facilities without seating or cashiers that prepare food exclusively for delivery. Wendy’s, with nine brick-and-mortar outlets in India, said it believes its cloud kitchen alliance is the largest yet in the industry. Rebel Foods, backed by Sequoia Capital and Goldman Sachs Group is the world’s largest cloud-kitchen operator with more than 300 locations.

Categories
Editorial

Stocks to Benefit from Potential Covid-19 Vaccines

The Covid-19 pandemic has caused a deep impact on people’s livelihoods and health. The economic and social disruption caused by this unprecedented pandemic is devastating. As of November 24, official data from John Hopkins University shows that there are more than 59 million confirmed cases of Covid-19 worldwide.

The only factor which keeps our spirits high is the fact that potential Covid-19 vaccine candidates are showing great results in the final stages of trials. Let us take a look at the updates of 4 major vaccines that could be supplied in India, as soon as they receive regulatory approvals.

  1. Oxford-AstraZeneca Vaccine
  2. Pfizer-BioNTech
  3. Gamaleya Institute-RDIF
  4. Bharat Biotech-ICMR
  5. Which Stocks Could Benefit from Vaccine?

Oxford-AstraZeneca

The AZD1222 Covid-19 vaccine is jointly developed by a Swedish-British pharma company AstraZeneca and the University of Oxford. According to trials conducted by the developers, the vaccine has shown an overall efficacy rate of 70%. An analysis issued by Oxford-AZ on 23rd November showed some very exciting results. The participants who received a lower amount of the vaccine in the first dose and then the full amount in the second dose were found to be 90% less likely to develop Covid.

The vaccine has also shown that it works across all age groups, and is also able to reduce asymptomatic infection. Another important feature of the Oxford-AZ vaccine is that it can be stored at normal fridge temperatures. This means that it would be cheaper to distribute and administer the vaccine to people. Experts believe that these 3 factors make this candidate a better choice, as compared to the results published by Pfizer and Moderna. There were no severe cases or hospitalisation in the 23,000 people who got the shot. 

The developers of the vaccine expect to supply 2.9 billion doses once they receive emergency use authorization. They have also stated that the vaccine would be made available in the UK first. The United States, the United Kingdom, and India are the main countries that have committed to buy a majority of its doses. The price of the shot has been set at $4-5.

It is expected to be cheaper in India, as the doses are also being manufactured by the Serum Institute of India (SII). The SII had partnered with AstraZeneca to develop the vaccine under the ‘Covidshield’ brand in our country There is a high chance that this vaccine will be the first to be administered to Indian citizens.

“The Serum Institute of India (SII) can apply for emergency use authorization (EUA) of the AstraZeneca and Oxford University’s COVID-19 vaccine in India once it is approved in the UK, since it is a partner developer” – Dr. Randeep Guleria, Director of AIIMS.

Pfizer-BioNTech

The Covid-19 vaccine candidate termed mRNA-BNT162 is being developed by US-based Pfizer Inc and Germany-based BioNTech. According to the final trials conducted by both companies, the vaccine has proven to be 95% effective in preventing Covid-19. Pfizer has approached the United States Food and Drug Administration (USFDA) to appeal for an emergency use authorization of its vaccine. However, a report on November 23 states that the USFDA will only assess the appeal on December 10.

Pfizer and BioNTech expect to supply 1.3 billion doses of the vaccine, as soon as they receive the approval from the USFDA. The United States, the UK, European Union, and Japan have already committed to buying the doses. The price per shot has been set at $20. Pfizer expects the vaccine to be rolled out by Christmas time in the United States.

On November 24, India’s Union Health Minister Harsh Vardhan said that India may not require the Pfizer-BioNTech vaccine. He stated that other vaccine candidates such as the one developed by Oxford-AZ are showing promising results. Also, the storage and distribution of Pfizer’s vaccine require an ultra-cold chain of minus 70 degrees. This would make it very expensive in India. However, based on India’s current Covid-19 situation, the government may consider buying a significant quantity of this vaccine.

Gamaleya Institute-RDIF

The Sputnik-V vaccine is being developed by Russia’s Gamaleya Research Centre and the Russian Direct Investment Fund (RDIF). They have partnered with Hyderabad-based Dr. Reddy’s to distribute the vaccine in India. According to the second interim analysis of 18,000 people who got the shot, the vaccine had an efficacy rate of 95%. They are currently undergoing Phase-3 trials with a total of 40,000 volunteers. RDIF has stated that Sputnik-V provides a stronger and longer-term immune response.

The developers of the vaccine expect to supply 1 billion doses of the vaccine, once they receive regulatory approvals. Russia, India, Vietnam, and Brazil have committed to buying the vaccine doses. The vaccine has been priced at $10 per shot.

Bharat Biotech-ICMR

Hyderabad-based Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) to develop India’s first indigenous Covid-19 vaccine- COVAXIN. The vaccine had initiated Phase-3 trials earlier this month with 26,000 volunteers from across 22 sites in India. This is the largest clinical trial conducted for a coronavirus vaccine candidate in India. On 22nd November, they announced that Covaxin will be at least 60% effective based on earlier trial results.

However, the company has not released the results of its Phase 1 & 2 results to the public. This makes us wonder about the actual effectiveness of the vaccine. The company expects the vaccine to be rolled out by mid-2021, after necessary approvals.

Which Stocks Could Benefit from Vaccine?

We can see that many sectors would benefit from the development of a vaccine in India. Whether it be manufacturing, storage, distribution, or administration of the vaccine, the support of many companies is needed. Earlier this month, it was announced that Pfizer’s vaccine needed a cold-storage facility to be stored and transported. On the same day, Snowman Logistics Ltd. said that they would create the necessary technology to provide logistical support for the vaccine.

Apollo Hospitals has also announced that they have the cold storage chain ready for Pfizer’s Covid-19 vaccine. They are ready to administer 10 lakh doses of the Covid-19 vaccine per day, once it is launched. The company has trained around 10,000 people to administer the vaccine in India.

Way back in July, Piramal Glass announced that they will be ready to supply more glass vials for the Covid-19 vaccines in India. They have taken proactive measures to meet any surge in demand for glass vials from the pharmaceutical industry across the globe. It has been estimated that India will require 6 crore vials for Covid-19 shots in the first six months of the vaccine being launched.

Dr. Reddy’s Laboratories will conduct all necessary trials and distribute the Sputnik-V coronavirus vaccine in India. The vaccine had arrived in Hyderabad on November 11, after regulators had approved to go ahead with the Phase-3 trial of the vaccine in India.

Just another thought that came into the team’s mind while brainstorming was that syringe manufacturers would also benefit from a vaccine. Companies like Albert David can be looked into. Also, diagnostic firms such as Dr. Lal PathLabs Ltd. would benefit from their Covid-19 testing facilities, until vaccines are launched.

What other sectors do you think will benefit from a Covid-19 vaccine?

Conclusion

As we can see, the Covid-19 vaccine candidates are showing great results. The vaccine developed by Oxford and AstraZeneca seems to be the most promising one, as compared to others. The developers of these vaccines are hopeful to supply it by the beginning of 2021. However, experts state that the distribution of the vaccine for all Indian citizens would be a major hurdle. For this, large pharmaceutical companies are also seeking logistical support from Indian firms to store and distribute vaccines. So, make sure that you follow news relating to such deals or orders.

The sentiments surrounding the efficiency of Covid-19 vaccine candidates have certainly lifted our spirits. However, do bear in mind that cases of Covid-19 are still rising, and many countries had even re-introduced lockdowns. Some parts of India are still reporting a large number of daily cases as well. Let us hope that the vaccine is available for every single citizen of India, once it is launched. 

Categories
Market News Top 10 News Top Global News

Boeing 737 MAX allowed to fly – Top 10 Global News

1. U.S. Stock Futures Rise

U.S. equity futures and European stocks rose on signs that scientists are making fast progress toward a vaccine. Bitcoin surged past $18,000 for the first time since December 2017. Pfizer gained 2.8% in pre-market trading after saying that its Covid-19 vaccine was 95% effective with no significant safety problems so far. The news paves the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days. Boeing added 6.7% as the Federal Aviation Administration ruled that the 737 Max will be cleared to fly after extensive fixes.

The tech-heavy Nasdaq 100 lags behind. Equity indexes were green across Europe in a broad-based advance.

Futures on the S&P 500 Index gained 0.3% as of early morning New York time.

The Stoxx Europe 600 Index rose 0.4%.

The MSCI Asia Pacific Index increased 0.2%.

The MSCI Emerging Market Index climbed 0.7%.

2. Pfizer, BioNTech Plan Filing as Vaccine Proves 95% Effective

Pfizer said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days. The U.S. drugmaker and partner BioNTech SE said their vaccine protected people of all ages and ethnicities, with no significant safety problems so far in a trial that includes almost 44,000 participants. The update is the latest in a string of promising developments on the vaccine front in recent days. 

3. Boeing Max Cleared to Fly as FAA Lifts Long U.S. Grounding

Boeing’s 737 Max can safely return to the skies with an extensive package of fixes, U.S. regulators ruled, after a scarring 20-month grounding prompted by a pair of fatal crashes. The actions, announced Wednesday by the Federal Aviation Administration, mark the end to the longest grounding of a jetliner in U.S. history and set the stage for airlines and other regulators around the world to resume passenger service with the plane. Boeing shares jumped 6.6%. They had lost 50% of their value since the March 10, 2019 crash of an Ethiopian Airlines Group flight that triggered the global grounding of the 737 Max.

4. Morgan Stanley Is Bullish on Tesla for First Time Since 2017

Morgan Stanley gave Tesla Inc. an overweight rating for the first time in more than three years, predicting that Elon Musk’s firm is on the verge of a “profound model shift” from selling cars to generating high-margin software and services revenue. The valuation now includes Tesla’s network services, energy storage and insurance businesses. The internet-of-cars opportunity is also real, and a prerequisite to unlock further gains for the stock, analysts wrote.

5. Tencent to Invest in Online Education Startup Udemy

Chinese technology company Tencent is a lead investor in a funding round that valued the online education startup Udemy at more than $3 billion. Investors were also told by Udemy that the company could pursue an IPO next year. Udemy said Wednesday that it has raised $50 million in a round valuing the company at $3.25 billion before the new investments.  Beyond its core gaming and social media empire, Tencent invests in China and increasingly outside it, grooming upstarts in everything from supplying fresh vegetables to building electric vehicles.

6. Apple to Cut App Store Fees in Half for Most Developers

Apple is cutting by half the fees charged to most developers who sell software and services on the App Store, marking the biggest change to the store’s revenue structure since the iPhone maker launched the service in 2008. The company is lowering the App Store fee to 15% from 30% for developers who produce as much as $1 million in annual revenue from their apps and those who are new to the store. The change will go into effect Jan. 1 as part of an App Store Small Business Program, Apple said Wednesday. The tech giant said it’s making the change to help small developers financially and to provide a way for them to invest in their businesses amid the economic struggles caused by the Covid-19 pandemic.

7. Bitcoin is back and it just soared past $18,000

Bitcoin reached $18,000 (INR 13.36 lakh) for the first time since just after the burst of the cryptocurrency bubble almost three years ago. The largest digital coin, which has more than doubled this year, surged as much as 6.2% on Tuesday in New York trading. From an all-time high in December 2017 of nearly $20,000, Bitcoin tumbled to as low as $3,136 (INR 2.32 lakh) within a year. Its gains this year follow a wider embrace from Wall Street linchpins, including Fidelity Investments, which launched a Bitcoin fund over the summer. PayPal said in October it would allow customers to access cryptocurrencies, which spurred bets more people could start to use digital tokens.

8. China to overtake 56 nations by 2025 in per capita income surge

The Asian powerhouse is forecast to have per capita gross domestic product, adjusted for purchasing power, equal to $25,307 (INR 18.78 lakh) in 2025. China’s surging economy is set to overtake 56 countries in the world’s per-capita income rankings during the quarter-century through 2025, the International Monetary Fund projects. By that date, China will rank 70th in the world on the metric, putting it close to joining the richest one-third of nations, according to data analyzed by Bloomberg from last month’s IMF World Economic Outlook.

9. Merkel Under Fire as Virus Strategy Sparks Anger From All Sides

Chancellor Angela Merkel came under pressure as a protest over her strategy to quell the coronavirus turned violent and a close ally issued a public rebuke. Berlin police used water cannons to break up a large demonstration near Brandenburg Gate on Wednesday. Participants — which totaled 14,000 people, according to police — refused to abide by distancing and hygiene rules, while some threw bottles and other objects. Pressure has been growing on German authorities, which are facing a crunch meeting next week to lay out a long-term plan to fight the pandemic. With restrictions likely to be extended and intensified, public anger and political tensions are rising.

10. Nissan’s Britain business tough to sustain without Brexit trade deal

Any final exit by Britain from the European Union that worsens business conditions through increased tariffs would threaten the sustainability of Nissan Motor Co’s UK operations, the Japanese car maker’s chief operating officer cautioned. Nissan, which employs 7,000 people at Britain’s biggest auto plant in the northeastern city of Sunderland called in June for an “orderly balanced Brexit”. But the latest warning comes as the EU cautions Britain it has fewer than 10 days left to secure a deal governing trade from next year.

Categories
Editorial

The Pfizer Vaccine – All You Need to Know

A major announcement from the United States on November 9 has completely lifted our hopes and spirits! Since March, scientists around the world have been working tirelessly towards creating an effective vaccine against the novel coronavirus. And now, drugmakers Pfizer and BioNTech have come out with a very positive result. The vaccine developed by the two companies was found to be 90% effective in preventing Covid-19 infections in ongoing Phase-3 trials.

We saw that the announcement made a ripple effect across the world, with the stock markets reaching new highs. Let us dive deep into the details of the vaccine, and recent developments surrounding it.

  1. Pfizer’s Covid-19 Vaccine Trials
  2. What Happened After the Announcement?
  3. Will the Vaccine be Available in India?
  4. Will a Vaccine Solve All Our Problems?

Pfizer’s Covid-19 Vaccine Trials

US-based Pfizer Inc and Germany-based biotechnology firm BioNTech had begun their collaboration in March 2020. Their partnership is aimed at co-developing and distributing a potential Covid-19 vaccine. Here are some important facts about the recent Phase-3 trials of the potential vaccine:

  1. The Phase-3 trials of the vaccine involved 44,000 participants in six countries. Half of them were administered with the vaccine, and the other half were given a placebo- a pill with no effect (like a sugar pill). A participant would not know if he got the vaccine or the placebo, thus helping to analyse the psychological effects.
  1. As per Pfizer’s interim analysis, the vaccine is 90% effective in preventing Covid-19 in participants who had no prior history of a SARS Cov-2 infection. However, Pfizer had not disclosed how many participants from the total number were used to formulate this interim analysis. In this sample, it is not clear how many had received the vaccine, and how many had received the placebo.
  1. Pfizer has stated that protection against the virus is achieved 28 days after the injection of the vaccine.
  1. The announcement made on November 9 offers the first compelling evidence that a vaccine can prevent Covid-19. Pfizer’s report from Phase-3 trials is being welcomed by other scientists around the world. It also puts Pfizer-BioNtech ahead of the other vaccine makers.
  1. Pfizer is planning to approach the United States Food and Drug Administration (USFDA) for emergency authorization of the vaccine later this month. Meanwhile, the Phase-3 trials will continue until there are 164 Covid-19 cases among the volunteers. This final analysis will confirm the actual percentage of effectiveness of the vaccine.
  1. An important factor to be noted is that experts in the field are yet to receive an answer on how much protection the vaccine offers, and for how long it would last. So, we can say that this announcement is being taken with “cautious optimism”.

What Happened After the Announcement?

Ever since Pfizer made the statement on Nov 9, we can see that important decisions are being taken at a very rapid pace. According to a statement from Pfizer, the company has plans to globally produce up to 50 million vaccine doses in 2020, and up to 1.3 billion doses in 2021.

Reports have also stated that many countries have already made deals with the drugmaker and have plans to hoard the vaccine. The US Government has signed a $1.95 billion (~Rs 14,474 crore) deal with Pfizer to buy 100 million doses. According to Alex Azar, the US Health Secretary, their government would begin vaccinating Americans in December. This is only possible if Pfizer submits the initial positive data from its vaccine trials to the USFDA, as soon as possible.

On the day of the announcement, Pfizer CEO Albert Bouria made a very calculated move. As per a regulatory filing, 1,32,508 Pfizer shares were sold by the CEO at a price of $42 per share. This means that he had sold $5.6 million of his shares in the company. This has raised many eyebrows as almost 62% of his entire stock in the company was sold right at the peak. Several questions have also been raised regarding the effectiveness of the vaccine after this high profile stake sale.

Will the Vaccine be Available in India?

Our Indian Government is now in discussions with Pfizer to make the vaccine available in our country. So far, the American firm does not have a distribution pact with any Indian company. It has been reported that India would soon sign an agreement with the US drugmaker. However, India has some significant hurdles to overcome to ensure that we can obtain Pfizer’s vaccine.

In a statement made on November 10, Kiran Mazumdar Shaw, the Managing Director of Biocon, stated that the Pfizer vaccine is unlikely to make its way to India. The reason that she had put forth was that the vaccine requires an ultra-cold chain of minus 70 degrees. This means that the vaccine has to be stored and transported in an ultra-cold facility. Currently, India does not have the necessary logistical support to conduct such a highly specialized task. The cost of the vaccine in India may also become very high due to this reason.

Around the same time, we had also received some positive statements from Snowman Logistics. The company has found an opportunity to improve its business, by creating a super-cold storage facility for Pfizer’s Covid-19 vaccine. Sunil Nair, the CEO of Snowman Logistics, has stated that they will come up with a technology to address these requirements. On November 10, the share price of Snowman Logistics saw a surge of 14% in an intraday movement to Rs 40.95. 

Last month, Apollo Hospitals had announced that they are ready to administer 10 lakh doses of the Covid-19 vaccine per day. Today, the company’s CEO, Sunita Reddy, has said that they have the cold storage chain ready for the Pfizer vaccine.

Will Vaccine Solve All Our Problems?

Scientists have yet again proved to become a worthy opponent in the fight against a deadly virus. We have finally received an amazing update from the vaccine makers. A very effective vaccine would hopefully be available all over the world soon. The news from Pfizer had also created a very positive sentiment around the global markets. We also saw our stock market indices reaching new highs.

Our Indian companies are also preparing to create a possible technology to store and transport the vaccine. All the issues caused by the Covid-19 pandemic would soon be countered. Although a vaccine would not immediately turn around the world economies, it gives hope that there will be a brighter future going ahead. As Indians and as human beings, in the face of a problem such as Covid, we will come back much stronger. The economic conditions could become more stable, and more importantly, things are finally looking very optimistic!

Let us look forward to the latest updates surrounding the vaccines, including many others from India and around the world. We must also be aware of how our country is planning to further gear up to make the vaccine available for all citizens. And as intelligent stock market participants, identify which all sectors will benefit from the announcement of a vaccine.

Categories
Market News Top 10 News Top Global News

Amazon faces price-war with Ambani in Diwali sales – Top 10 Global News

1. Europe Defensive Stocks Rise; Tech Stocks Selloff Pauses

Defensive shares including health-care stocks advanced in Europe alongside U.S. futures, helping prolong a global rally in equities. Crude oil jumped for the third day. The Stoxx Europe 600 Index climbed 1% to its highest level since late February as defensives including grocery stores and real estate also rose. Equity gauges rose across much of Asia despite the tech selloff in China that deepened after Beijing’s crackdown on Internet and fintech firms. In the U.S. the tech picture was more positive, with Nasdaq 100 futures rebounding as much as 1.4%. 

Futures on the S&P 500 Index climbed 0.8% as of early morning New York time.

Nasdaq 100 Index futures gained 1.2%.

The Stoxx Europe 600 Index increased 1%.

The MSCI Asia Pacific Index advanced 0.6%.

2. Record U.S. Hospitalizations; Russia Vaccine Data – COVID Update

A resurgence of cases and deaths continued in Europe, with Germany reporting its highest daily fatalities since mid-April. A state premier warned that German Christmas markets and religious services may be in jeopardy with the current rate of infection. The coronavirus is also returning in U.S. cities. Hospitalizations in the country reached a record, and cases topped 1 million in the first 10 days of November alone. The developer of Russia’s flagship vaccine said it shows a 92% efficacy rate in preventing infections, as the country pushes for a top slot in the virus fight after Pfizer reported a similar breakthrough.

3. OPEC Cuts Demand Estimate for Its Crude Again Amid New Lockdowns

OPEC once again cut estimates for the amount of crude it will need to provide in the coming year as the return of measures to contain the global pandemic hits fuel use. The virus’s effects will “linger” next year even with the announcement of a vaccine breakthrough, the group said. The group reduced forecasts — from estimates in its previous report — for the volume of crude it needs to pump this quarter by 960,000 barrels a day to 26.51 million a day. This follows significant downgrades in the past two months.

4. Deep-Freeze Hurdle Makes Pfizer’s Vaccine One for the Rich

When Pfizer and BioNTech’s Covid-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of deep-freeze airport warehouses, refrigerated vehicles and inoculation points across China. After they reach vaccination centres, the shots must be thawed from -70 degrees celsius and injected within five days, if not they go bad. Then the herculean journey from warehouse freezer to rolled-up sleeve must be undertaken all over again — to deliver the second booster shot a month later. The roadmap sketched out by the company, which has licensed the vaccine for Greater China, offers a glimpse into the enormous and daunting logistical challenges faced by those looking to deliver Pfizer’s experimental vaccine after it showed “extraordinary” early results from final-stage trials, making it practical only for rich and developed countries.

5. Asia’s Richest Man Takes on Amazon in India’s Booming Online Market

Billionaire Mukesh Ambani obliterated rivals in India’s telecommunications sector by selling the cheapest data plans and free voice calls. Four years later, he’s deploying a very similar tactic — cutthroat pricing — to gain an edge in the country’s increasingly competitive e-commerce space. As India this week hits the peak of its biggest shopping season, the festival of Diwali, the tycoon’s retail websites — including JioMart — are elbowing their way into a space long dominated by Amazon.com and Walmart’s local unit Flipkart. Ratcheting up competition, Ambani’s portals are offering blockbuster discounts of as much as 50% on popular sugary confections and other holiday staples like spice mixes for India’s rice delicacy, biryani. Meanwhile, his Reliance Digital website is selling some flagship Samsung smartphones at prices cheaper than rivals, with as much as 40% discounts.

6. Saudi Aramco Proposes Selling Gas to China to Build on Oil Ties

Saudi Aramco wants to sell natural gas to China to help its biggest customer for oil make the transition to cleaner fuels, Chief Executive Officer Amin Nasser said. The Saudis, who have fought to remain among China’s largest crude suppliers, are also looking at options to develop and supply energy sources such as hydrogen and new kinds of chemicals to broaden their relationship with China.

7. Alibaba Leads Chinese Internet Selloff Nearing $290 Billion

Chinese technology giants from Alibaba Group Holding Ltd. and Tencent Holdings Ltd shed almost $290 billion of market value over two days of frantic selling, as investors scrambled to assess the fallout from China’s broadest attempt to control its most powerful private-sector firms. Technology shares tumbled for a second day after China issued regulations designed to curb the growing influence of internet-sector leaders including JD.com Inc., Meituan and Xiaomi Corp. The Hang Seng Tech Index slumped more than 6% on Wednesday in Hong Kong, taking its two-day loss to 11%. China on Tuesday unveiled regulations to root out monopolistic practices in the internet industry, pivoting away from a mostly hands-off approach while dealing a blow to businesses at the heart of the world’s No. 2 economy. 

8. Hong Kong-Singapore travel bubble to begin on November 22

A travel bubble between Hong Kong and Singapore will begin on November 22, the two cities announced on Wednesday, as they moved to re-establish overseas travel links and lift the hurdle of quarantine for visiting foreigners. Hong Kong’s Commerce Secretary and Singapore’s Transport Minister said the scheme would begin with one flight a day into each city, with a quota of 200 travellers per flight. This would be increased to two flights a day into each city from December 7. If the COVID-19 situation deteriorated in either city the travel bubble would be suspended, they said. Singapore’s Transport Minister Ong Ye Kung said he believed the travel bubble was the first of its kind in the world and enabled both cities to open up borders in a controlled manner while maintaining safety. Travellers from both cities must travel on designated flights and must undertake COVID-19 tests within 72 hours before their departure, while people arriving in Hong Kong must take a second test at the airport. They must also have no history of travel to any places other than Singapore or Hong Kong in the 14 days prior to departure.

9. China’s Singles’ Day bags record shopping revenues

Chinese e-commerce giant Alibaba Group Holding Ltd said orders made during its Singles’ Day mega-shopping festival had exceeded $56bn (INR 4.2 lakh cr) by Wednesday morning, as consumers sought to cash in on a deluge of discounts. This year’s shopping extravaganza comes a week after Alibaba lost almost 6% of its market value following China’s suspension of the IPO listing of Ant Group, the financial technology firm which Alibaba owns a third of. It also takes place as China experiences an economic rebound after getting the spread of the novel coronavirus under control within its borders, following the virus’ emergence in the central city of Wuhan late last year.

10. Norwegian Air furloughs staff, pleads for help to survive in 2021

Already heavily in debt, Norwegian Air sees its problems exacerbated by the coronavirus pandemic. Norwegian Air’s cash crisis could force the debt-laden budget airline to halt operations early next year, the company warned as it issued another plea for rescue funding after reporting quarterly results on Tuesday. The rapid expansion of the pioneer in low-fare transatlantic flights has left it with heavy debts and problems that have been compounded by the COVID-19 pandemic. It is now serving domestic routes only, with just 6 of its 140 aircraft flying. Its latest plea comes after Norway’s government on Monday rejected calls for more state support for the airline, the shares of which have lost 99% of their value since January, saying it would be too risky. Following that rejection, the company said that it would furlough 1,600 more staff, leaving only 600 people still working out of its total 10,000 workers before the pandemic.

Categories
Market News Top 10 News Top Global News

Pfizer’s Covid-19 Vaccine Prevents 90% Infections – Top 10 Global News

1. Joe Biden Wins U.S. Presidency After Bitter Contest With Trump

Joseph Robinette Biden Jr. has defeated Donald Trump to become the 46th U.S. president, unseating the incumbent with a pledge to unify and mend a nation reeling from a worsening pandemic, faltering economy and deep political divisions. Biden’s victory came after the Associated Press, CNN and NBC showed him winning Pennsylvania and Nevada and gaining more than the 270 Electoral College votes needed to secure the presidency. Biden was at home with his family when he learned he’d won the election, a campaign aide said.

2. Stocks Surge to All-Time High on Vaccine Progress

The clearest sign yet of progress on a Covid-19 vaccine is fueling a rally across global stock markets. The strongest gains in the market were among small-cap stocks, which have been hit hard by the economic toll of lockdowns. Futures on the Russell 2000 Index of small-cap stocks jumped 7% and S&P 500 contracts rose 4.2%. Nasdaq 100 Index futures pared gains, but were still up 0.5%.

Futures on the S&P 500 Index surged 3.4% as of early morning NY time.

The Stoxx Europe 600 Index surged 4.5%.

The MSCI Asia Pacific Index increased 1.1%.

The MSCI Emerging Market Index gained 1.7%.

3. Pfizer’s Covid Vaccine Prevents 90% of Infections in Study

The Covid-19 vaccine being developed by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a study of tens of thousands of volunteers, the most encouraging scientific advance so far in the battle against the coronavirus. Eight months into the worst pandemic in a century, the preliminary results pave the way for the companies to seek an emergency-use authorization from regulators if further research shows the shot is also safe.

4. Gold set for best week since July as Biden closes in on victory

Gold headed for the biggest weekly gain since July and copper rose as Joe Biden tightened his grip on the race for the White House, while investors also weighed prospects for further Federal Reserve stimulus under the Biden presidency. Gold bullion broke out of a narrow trading range seen over the past month as uncertainty over the election and renewed stimulus hopes boosted demand for the haven. 

5. China’s Yuan Extends Best Week Since 2017 on Biden’s Victory

The yuan extended its recent rally as the dollar weakened following Joe Biden’s presidential victory in the U.S. The offshore yuan was 0.37% stronger in Hong Kong, following last week’s 1.6% surge that was the biggest gain since January 2017. The currency has been on a rise since the start of June as China’s economy rebounded, and China’s currency has rallied to a more than two-year high.

6. Global Stocks Surge to Record High on Biden Presidency

Global equities jumped to a record high amid optimism about the outlook for risk assets during a Joe Biden presidency. The MSCI All-Country World Index rose as much as 0.5% on Monday, surpassing its previous highs. After surging nearly 8% last week in the biggest rally since April, global stocks on Monday extended their gains after Biden was declared the winner of the U.S. election over the weekend. Biden in his victory speech promised swift action against the pandemic and an orderly transfer of power, though President Donald Trump is weighing legal challenges and has so far refused to concede.

7. EU Gives Green Light to Trigger $4 Billion Tariff Strike on U.S.

European Union trade ministers gave the go-ahead for EU tariffs on $4 billion (29,500 cr) of American goods in retaliation over illegal aid to Boeing, seeking to prod the U.S. to scrap its duties prompted by unlawful subsidies to Airbus. The green light paves the way for the European Commission, the EU’s executive arm in Brussels, to trigger the import levies on Monday. U.S. aircraft-related products as well as other goods ranging from spirits and nuts to handbags and chemicals were included on the bloc’s planned target list last month. The imminent tariff strike is meant to give the EU more leverage in pushing for a truce that has been elusive with the U.S. President Donald Trump, who will remain in office until Jan. 20. The tit-for-tat move may make it easier for President-elect Joe Biden to embrace longstanding European calls to settle the transatlantic dispute over aircraft aid at the negotiating table.

8. SoftBank Posts Vision Fund’s Record Profit

Masayoshi Son is making his case for SoftBank’s turnaround. The Japanese conglomerate reported a record $7.6 billion (INR 56,000 cr) profit in its Vision Fund business for the three months ended Sept. 30, a sign the fund’s investments in startups are paying off amid a broad rally in technology stocks. One Chinese startup quadrupled SoftBank’s money after going public in August.

9. French bank Societe Generale to cut 640 jobs in France, no forced redundancies

French bank Societe Generale said on Monday it planned a net reduction of about 640 positions in France but said there would be no forced redundancies. The bank said the plan would concern market activities and associated functions and would help reduce costs by about $535 million (INR 4000 cr) by 2022-2023. French business newspaper Les Echos reported on Sunday that the cuts would be mainly in the investment banking division.

10. Oil-Rich Abu Dhabi to Start Trading Crude Futures From March

Oil-rich Abu Dhabi will open a commodities exchange in March to rival those of Middle Eastern neighbours, letting investors trade its crude using futures contracts for the first time. The ICE Futures Abu Dhabi exchange will open on March 29 and offer contracts based on the emirate’s flagship Murban crude grade, pending regulatory approvals. The Atlanta-based operator of trading and clearing platforms is setting up the exchange with government producer Abu Dhabi National Oil Co. and other oil suppliers. Abu Dhabi is the capital of the United Arab Emirates — OPEC’s third-largest producer — and it holds most of the UAE’s oil. Murban crude, pumped from onshore fields, comprises more than half of the country’s output, now at around 2.6 million barrels daily.

Categories
Market News Top 10 News

Pfizer’s Covid-19 Vaccine 90% Effective in Phase 3 – Top Indian Market News

Covid-19 vaccine 90% effective in Phase-3 trial: Pfizer

Pfizer, the US-based pharmaceutical firm, has stated that its vaccine was 90% effective in preventing Covid-19 infections in ongoing Phase-3 trials. The vaccine candidate is jointly developed by Pfizer and BioNTech. Pfizer has also stated that it expects to supply up to 50 million vaccine doses globally in 2020.

Read more here.

RBI lifts restrictions on Equitas Small Finance Bank after listing of shares

Equitas Holdings Ltd. has stated that the Reserve Bank of India has lifted the restrictions that were imposed on Equitas Small Finance Bank (ESFB) in September 2019. RBI had restricted ESFB from opening new branches and froze the remuneration of its MD & CEO. The restrictions were removed after ESFB got listed on the stock exchanges earlier this month.

Read more here.

Balkrishna Industries Q2 Results: Net Profit rises 16% YoY to Rs 339 crore

Balkrishna Industries Ltd. reported a 16.7% year-on-year (YoY) increase in net profit to Rs 339.5 crore, for the quarter ended September (Q2). The company posted a 36% YoY increase in sales volume to 61,224 million tonnes, during the same period. The board has declared an interim dividend of Rs 4 per share.

Read more here.

Happiest Minds partners with AutonomIQ to create connected ecosystem

Happiest Minds Technologies has partnered with AutonomIQ, a cloud platform that uses AI and machine learning for testing solutions. The partnership will be aimed at accelerating the enterprise digital transformation journey using autonomous testing capabilities. The companies will also help to create pre-built solutions to help customers generate value in really short periods. 

Read more here.

L&T Finance Holdings gets approval to raise Rs 3,000 crore via rights issue

The Board of Directors of L&T Finance Holdings has approved a plan to raise Rs 3,000 crore through a rights issue. A rights issue is a method used by a company to raise additional capital, by offering more of its shares to the current shareholders. The company has stated that the details of the rights issue, including price and entitlement ratio, will be determined in due course.

Read more here.

Blue Star receives Rs 128 crore order from Wistron Infocomm

Blue Star, on Monday, announced that it has bagged a Rs 128 crore order from Wistron Infocomm. The order is to create a mechanical electrical and plumbing (MEP) structure for Wistron’s factory expansion project. Wistron Infocomm is a Taiwan-based contract manufacturer of electronic goods for companies such as Apple.

Read more here.

Board of Granules India approves incorporation of subsidiary in Hyderabad

The Board of Directors of Granules India has approved to incorporate a wholly-owned subsidiary of the company in Hyderabad. The company has plans to build a green field facility for its formulations business. The share price of Granules India Ltd. saw a rise of 4.24%, and closed at Rs 387 on the NSE today.

Read more here.

Jindal Saw Q2 Results: Net Profit falls 74% YoY to Rs 78 crore

Jindal Saw Ltd. reported a 74% year-on-year (YoY) decline in net profit to Rs 78.2 crore, for the quarter ended September (Q2). The company’s revenue declined by 11.5% YoY to Rs 2,374.32 crore, during the same period. Jindal Saw has stated that its sales have seen a sharp rebound, after the steel business was negatively impacted due to Covid-19.

Read more here.

Parag Milk Foods Q2 Results: Profit declines 44% YoY to Rs 16 crore

Parag Milk Foods Ltd. reported a 44.19% year-on-year (YoY) decline in profit after tax to Rs 15.9 crore, for the quarter ended September (Q2). Its revenue declined by 22.16% YoY to Rs 498.23 crore, during the same period. The company has stated that revenues had fallen due to a slowdown in its Hotel, Restaurants, and Catering segment.

Read more here

Lumax Industries Q2 Results: Net Profit falls 63% YoY to Rs 7 crore

Lumax Industries Ltd. reported a 63.99% year-on-year (YoY) decline in net profit to Rs 7.23 crore, for the quarter ended September (Q2). The company’s revenue declined by 7.39% YoY to Rs 397.35 crore, during the same period. Lumax is a leading manufacturer and supplier of automotive components and systems in India.

Read more here.

NLC India Q2 Results: Net Profit jumps 400% YoY to Rs 43 crore

NLC India Limited reported a 400% year-on-year (YoY) increase in net profit to Rs 43 crore, for the quarter ended September (Q2). The company’s revenue increased by 78% YoY to Rs 396 crore, during the same period. The board has declared an interim dividend of Rs 1.5 per share. NLC India is a Government-owned company in the fossil fuel mining sector.